Total Payments
$3,979
2024 Payments
$597.25
Companies
30
Transactions
234
Medicare Patients
1,383
Medicare Billing
$70,718
Payment Breakdown by Category
Food & Beverage$3,910 (98.2%)
Education$69.68 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,910 | 232 | 98.2% |
| Education | $69.68 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $724.09 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $600.37 | 27 | $0 (2024) |
| PFIZER INC. | $285.01 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $284.20 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $241.16 | 8 | $0 (2023) |
| Boston Scientific Corporation | $207.20 | 3 | $0 (2024) |
| ABBVIE INC. | $189.42 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $169.07 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $156.88 | 14 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $154.78 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $597.25 | 31 | Janssen Pharmaceuticals, Inc ($107.91) |
| 2023 | $504.25 | 29 | ABBVIE INC. ($144.64) |
| 2022 | $174.46 | 1 | Boston Scientific Corporation ($174.46) |
| 2020 | $152.26 | 11 | Novo Nordisk Inc ($45.96) |
| 2019 | $1,267 | 81 | AstraZeneca Pharmaceuticals LP ($409.19) |
| 2018 | $1,077 | 72 | Novo Nordisk Inc ($288.42) |
| 2017 | $207.13 | 9 | Valeant Pharmaceuticals North America LLC ($108.84) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Hyperthyroidism | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.93 | General |
| Category: Medical Device | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PAIN | ||||||
| 07/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: PAIN | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Diabetes Care | ||||||
| 04/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: DIABETES | ||||||
| 04/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Inflammation | ||||||
| 04/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Neuroscience | ||||||
| 04/02/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Neuroscience | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: PAIN | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 133 | 236 | $61,863 | $20,439 |
| 2022 | 6 | 170 | 228 | $43,368 | $12,858 |
| 2021 | 4 | 89 | 142 | $29,694 | $11,944 |
| 2020 | 14 | 991 | 1,219 | $81,567 | $25,478 |
Total Patients
1,383
Total Services
1,825
Medicare Billing
$70,718
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 124 | $31,620 | $9,612 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 67 | $22,646 | $8,269 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 22 | $3,806 | $1,226 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,456 | $1,018 | 29.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $335.00 | $312.84 | 93.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 126 | $25,452 | $7,654 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $8,170 | $2,443 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,287 | $1,474 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 25 | $3,425 | $887.32 | 25.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $517.00 | $299.20 | 57.9% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $517.00 | $100.08 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 86 | $17,372 | $7,407 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $3,225 | $1,885 | 58.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $6,220 | $1,404 | 22.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 21 | $2,877 | $1,248 | 43.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 107 | 197 | $36,222 | $12,501 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 29 | 29 | $6,032 | $3,199 | 53.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 63 | $8,570 | $3,051 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 484 | 562 | $8,992 | $1,669 | 18.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 65 | 75 | $4,050 | $785.91 | 19.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 42 | 46 | $2,484 | $767.02 | 30.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 46 | 48 | $3,456 | $637.59 | 18.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 14 | $1,904 | $603.13 | 31.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 67 | 76 | $2,964 | $586.20 | 19.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 33 | 48 | $2,496 | $462.66 | 18.5% |
About Dr. Jacqueline Gentry, MD
Dr. Jacqueline Gentry, MD is a Family Medicine healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1750709192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacqueline Gentry, MD has received a total of $3,979 in payments from pharmaceutical and medical device companies, with $597.25 received in 2024. These payments were reported across 234 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,910).
As a Medicare-enrolled provider, Gentry has provided services to 1,383 Medicare beneficiaries, totaling 1,825 services with total Medicare billing of $70,718. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Chattanooga, TN
- Active Since 04/02/2014
- Last Updated 08/15/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750709192
Products in Payments
- FARXIGA (Drug) $362.61
- Ozempic (Drug) $333.96
- VRAYLAR (Drug) $200.37
- Victoza (Drug) $193.63
- WATCHMAN Access System (Device) $174.46
- XIFAXAN (Drug) $160.44
- ENTRESTO (Drug) $154.78
- JARDIANCE (Drug) $143.95
- SPRAVATO (Drug) $139.69
- MYRBETRIQ (Drug) $137.05
- FASENRA (Drug) $124.99
- Trintellix (Drug) $119.07
- Tresiba (Drug) $118.00
- Otezla (Drug) $80.63
- XARELTO (Drug) $78.84
- INVOKANA (Drug) $65.67
- AIRSUPRA (Drug) $59.93
- PREVNAR - 13 (Biological) $58.80
- FreeStyle Libre (Device) $56.67
- CHANTIX (Drug) $52.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chattanooga
David Close, Md, MD
Family Medicine — Payments: $17,579
Family Medicine $17,579
Ellen Cleland, Md, MD
Family Medicine — Payments: $13,669
Family Medicine $13,669
Richard Moody, Md, MD
Family Medicine — Payments: $13,575
Family Medicine $13,575
Dr. Synthia Beeler, Md, MD
Family Medicine — Payments: $13,169
Family Medicine $13,169
Siobhan Duff, Md, MD
Family Medicine — Payments: $11,695
Family Medicine $11,695
Dr. Christina Oskins, Md, MD
Family Medicine — Payments: $8,910
Family Medicine $8,910